Biological Products, (No Diagnostic Substances) Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Biological Products, (No Diagnostic Substances)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear

100 results. Finviz
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company Name

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2021-04-15
REPLReplimune Group, Inc.Love ColinCOOS - Sale$30.63-30,000895,809-3%-$918,783
D
2021-04-15
NSTGNanostring Technologies IncHershberg RobertDirS - Sale+OE$73.91-1441,890-7%-$10,642
DM
2021-04-15
DTILPrecision Biosciences IncJantz DerekChief Scientific OfficerS - Sale+OE$8.80-19,3514,004,9210%-$170,289
2021-04-16
WINTWindtree Therapeutics Inc /de/Hamill John P.SVP, CFOP - Purchase$2.07+1,0003,500+40%+$2,067
2021-04-15
WINTWindtree Therapeutics Inc /de/Fraser CraigPres, CEOP - Purchase$2.24+1,00029,445+4%+$2,240
M
2021-04-14
SWTXSpringworks Therapeutics, Inc.Squinto Stephen PDir, 10%S - Sale$75.04-1,568145,160-1%-$117,655
2021-04-14
TARSTarsus Pharmaceuticals, Inc.Vivo Capital Ix, LLC10%S - Sale$30.37-4003,244,6350%-$12,148
D
2021-04-15
ADPTAdaptive Biotechnologies CorpLo FrancisChief People OfficerS - Sale+OE$43.04-2,00023,104-8%-$86,080
D
2021-04-14
ADPTAdaptive Biotechnologies CorpBaldo LanceChief Medical OfficerS - Sale+OE$44.50-2,00022,894-8%-$89,000
D
2021-04-14
ADPTAdaptive Biotechnologies CorpGriffin Michelle ReneeDirS - Sale+OE$43.41-4,5001,504-75%-$195,345
2021-04-15
JNCEJounce Therapeutics, Inc.Higgons John DuncanDirS - Sale$10.00-2009,713-2%-$2,000
D
2021-04-15
MRNAModerna, Inc.Henderson Lori M.GC, SecretaryS - Sale+OE$158.76-6,600901-88%-$1,047,816
M
2021-04-14
MRNAModerna, Inc.Bancel StephaneCEOS - Sale$156.39-19,00022,939,4580%-$2,971,350
D
2021-04-14
MRNAModerna, Inc.Andres JuanSee remarksS - Sale+OE$153.75-5,0000-100%-$768,750
D
2021-04-15
ALLOAllogene Therapeutics, Inc.Bhavnagri VeerGCS - Sale+OE$32.05-10,000421,353-2%-$320,517
M
2021-04-13
HARPHarpoon Therapeutics, Inc.Mpm Bioventures 2014, L.P.Former 10% OwnerS - Sale$20.16-4,6663,220,8440%-$94,075
M
2021-04-13
HARPHarpoon Therapeutics, Inc.Gadicke Ansbert10%S - Sale$20.16-38,5567,067,244-1%-$777,359
D
2021-04-12
SRNESorrento Therapeutics, Inc.Janda KimDirS - Sale+OE$6.97-1,9003,000-39%-$13,251
D
2021-04-14
AMGNAmgen IncSugar Ronald DDirS - Sale+OE$249.98-1,00015,927-6%-$249,980
D
2021-04-13
VIRVir Biotechnology, Inc.Virgin HerbertEVP, Research, CSOS - Sale+OE$43.57-5,56088,200-6%-$242,244
D
2021-04-12
TWSTTwist Bioscience CorpLeproust Emily M.Pres, CEOS - Sale+OE$128.71-2,000265,843-1%-$257,414
AD
2021-03-30
IKNAIkena Oncology, Inc.Bonita David PDirP - Purchase$16.00+423,400248,302-242%+$6,774,400
D
2021-04-12
DTILPrecision Biosciences IncKane Matthew R.Pres, CEOS - Sale+OE$8.67-9,7411,975,6370%-$84,454
2021-04-14
HALOHalozyme Therapeutics, Inc.Kelley Kenneth JDirS - Sale$45.00-5,000179,833-3%-$225,000
D
2021-04-13
MRNAModerna, Inc.Henderson Lori M.GC, SecretaryS - Sale+OE$146.62-6,600901-88%-$967,692
DM
2021-04-12
MRNAModerna, Inc.Hoge StephenPresS - Sale+OE$145.58-20,0001,765,646-1%-$2,911,600
D
2021-04-12
BDTXBlack Diamond Therapeutics, Inc.Hatzis-Schoch BrentSee RemarksS - Sale+OE$25.00-4,0788,400-33%-$101,950
D
2021-04-13
SWTXSpringworks Therapeutics, Inc.Smith L. MaryChief Development OfficerS - Sale+OE$68.07-10,000167,511-6%-$680,723
M
2021-03-16
NSTGNanostring Technologies IncGray R BradleyPres, CEOS - Sale$66.03-26,863169,803-14%-$1,773,748
A
2021-03-16
NSTGNanostring Technologies IncGray R BradleyPres, CEOS - Sale$66.32-8,817196,666-4%-$584,743
A
2021-03-10
NSTGNanostring Technologies IncGray R BradleyPres, CEOS - Sale$62.04-33,333129,174-21%-$2,068,062
2021-03-25
NSTGNanostring Technologies IncBrown J. ChadSVP, Sales, MarketingS - Sale$68.78-4,9480-100%-$340,323
A
2021-03-16
NSTGNanostring Technologies IncBrown J. ChadSVP, Sales, MarketingS - Sale$66.32-1,3359,702-12%-$88,537
M
2021-03-16
NSTGNanostring Technologies IncBeechem Joseph MSVP, Research, DevelopmentS - Sale$66.00-10,03580,035-11%-$662,327
A
2021-03-16
NSTGNanostring Technologies IncBeechem Joseph MSVP, Research, DevelopmentS - Sale$66.32-1,77890,070-2%-$117,917
2021-03-16
NSTGNanostring Technologies IncBailey K ThomasCFOS - Sale$66.32-1,16118,155-6%-$76,998
A
2021-03-16
NSTGNanostring Technologies IncBailey K ThomasCFOS - Sale$66.32-1,33519,316-6%-$88,537
AD
2021-03-30
IKNAIkena Oncology, Inc.Orbimed Advisors LLCDirP - Purchase$16.00+423,400248,302-242%+$6,774,400
2021-04-09
ITOSIteos Therapeutics, Inc.Mpm Bioventures 2014, L.P.10%S - Sale$29.99-1193,665,7870%-$3,569
2021-04-09
ITOSIteos Therapeutics, Inc.Mpm Bioventures 2018, L.P.10%S - Sale$29.99-1193,665,7870%-$3,569
2021-04-09
ITOSIteos Therapeutics, Inc.Gadicke Ansbert10%S - Sale$29.99-2006,004,3680%-$5,998
D
2021-04-12
MRNAModerna, Inc.Zaks Tal ZviChief Medical OfficerS - Sale+OE$138.96-5,0000-100%-$694,818
M
2021-04-09
HARPHarpoon Therapeutics, Inc.Gadicke Ansbert10%S - Sale$21.90-30,9287,105,8000%-$677,357
D
2021-04-12
MRNAModerna, Inc.Andres JuanSee remarksS - Sale+OE$142.46-5,0000-100%-$712,300
M
2021-04-09
HARPHarpoon Therapeutics, Inc.Mpm Bioventures 2014, L.P.10%S - Sale$23.15-12,7963,225,5100%-$296,261
2021-04-09
MRNAModerna, Inc.Bancel StephaneCEOS - Sale$140.91-11,04622,960,4580%-$1,556,482
DM
2021-04-08
KYMRKymera Therapeutics, Inc.Mainolfi NelloCEOS - Sale+OE$33.62-48,000376,199-11%-$1,613,563
2021-04-09
EIGREiger Biopharmaceuticals, Inc.Dietz Thomas JohnDirP - Purchase$8.49+2,50037,500+7%+$21,220
M
2021-04-08
RVMDRevolution Medicines, Inc.Svennilson PeterDirS - Sale$44.46-70,9293,206,085-2%-$3,153,745
DM
2021-04-08
DTILPrecision Biosciences IncKane Matthew R.Pres, CEOS - Sale+OE$8.94-19,4731,963,864-1%-$173,991
DM
2021-04-08
SGENSeagen Inc.Siegall Clay BPres, CEOS - Sale+OE$143.79-29,353715,209-4%-$4,220,740
M
2021-04-07
ITOSIteos Therapeutics, Inc.Gadicke Ansbert10%S - Sale$30.99-41,9826,004,568-1%-$1,300,850
D
2021-04-08
MRNAModerna, Inc.Henderson Lori M.GC, SecretaryS - Sale+OE$132.85-6,600901-88%-$876,810
M
2021-04-07
MRNAModerna, Inc.Bancel StephaneCEOS - Sale$132.27-19,00022,971,5040%-$2,513,170
M
2021-04-07
ITOSIteos Therapeutics, Inc.Mpm Bioventures 2014, L.P.10%S - Sale$30.99-25,0873,655,906-1%-$777,343
M
2021-04-07
ITOSIteos Therapeutics, Inc.Mpm Bioventures 2018, L.P.10%S - Sale$30.99-25,0873,655,906-1%-$777,343
2021-04-07
ADPTAdaptive Biotechnologies CorpAdams R MarkCOOS - Sale$42.34-3,58667,018-5%-$151,831
DM
2021-04-06
ADPTAdaptive Biotechnologies CorpCohen Chad MCFOS - Sale+OE$41.30-20,00021,604-48%-$826,005
M
2021-04-06
ADPTAdaptive Biotechnologies CorpRobins Chad MCEO, COBS - Sale$41.81-15,0001,748,461-1%-$627,107
D
2021-04-07
ALECAlector, Inc.Paul RobertChief Medical OfficerS - Sale+OE$19.20-22,300213,719-9%-$428,050
2021-04-06
RGENRepligen CorpBylund JamesSVP, Global Operations, ITS - Sale$204.25-3606,324-5%-$73,530
2021-04-07
WINTWindtree Therapeutics Inc /de/Curtis EricSVP, COOP - Purchase$2.52+7911,291+158%+$1,991
D
2021-04-07
MRNAModerna, Inc.Andres JuanSee remarksS - Sale+OE$131.63-5,0000-100%-$658,150
D
2021-04-06
MRNAModerna, Inc.Henderson Lori M.GC, SecretaryS - Sale+OE$130.01-6,600901-88%-$858,066
D
2021-04-05
TWSTTwist Bioscience CorpFinn Patrick JohnChief Commercial OfficerS - Sale+OE$126.72-2,70242,744-6%-$342,397
M
2021-04-05
RVMDRevolution Medicines, Inc.Svennilson PeterDirS - Sale$46.96-85,6683,243,704-3%-$4,023,041
2021-04-05
VYGRVoyager Therapeutics, Inc.Hesslein Robert W.SVP, GCS - Sale$4.95-3,292110,056-3%-$16,295
D
2021-04-05
BDTXBlack Diamond Therapeutics, Inc.Roberts Christopher D.Chief Scientific OfficerS - Sale+OE$25.54-2,5003,200-44%-$63,848
DM
2021-04-05
NVAXNovavax IncTrizzino JohnEVP, Chief Commercial OfficerS - Sale+OE$189.38-3,212287-92%-$608,296
2021-04-05
BLUEBluebird Bio, Inc.Obenshain AndrewPres of SGDS - Sale$30.21-2940,1370%-$876
2021-04-05
BLUEBluebird Bio, Inc.Leschly NickPres, CEOS - Sale$30.21-444475,8350%-$13,411
2021-04-05
BLUEBluebird Bio, Inc.Gregory Philip DChief Scientific OfficerS - Sale$30.21-3946,8680%-$1,178
2021-04-05
BLUEBluebird Bio, Inc.Cole JasonCOO andS - Sale$30.21-3747,9600%-$1,118
2021-04-05
BLUEBluebird Bio, Inc.Davidson DavidChief Medical OfficerS - Sale$30.21-4247,7870%-$1,269
2021-04-05
ATRAAtara Biotherapeutics, Inc.Newell JoeChief Operations OfficerS - Sale$14.74-655134,9240%-$9,655
2021-04-06
WINTWindtree Therapeutics Inc /de/Fraser CraigPres, CEOP - Purchase$2.57+50028,445+2%+$1,285
2021-04-05
XFORX4 Pharmaceuticals, IncRagan PaulaPres, CEOS - Sale$9.17-2,400415,152-1%-$22,008
2021-04-05
DNLIDenali Therapeutics Inc.Schuth Alexander O.COO, SecretaryS - Sale$56.09-10,000612,626-2%-$560,901
D
2021-04-05
CCCCC4 Therapeutics, Inc.Crystal AdamChief Medical OfficerS - Sale+OE$37.77-15,0000-100%-$566,536
2021-04-05
WINTWindtree Therapeutics Inc /de/Fraser CraigPres, CEOP - Purchase$2.58+1,00027,945+4%+$2,580
D
2021-04-05
MRNAModerna, Inc.Zaks Tal ZviChief Medical OfficerS - Sale+OE$129.71-5,0000-100%-$648,530
D
2021-04-05
MRNAModerna, Inc.Andres JuanSee remarksS - Sale+OE$132.63-5,0000-100%-$663,150
D
2021-04-05
MRNAModerna, Inc.Hoge StephenPresS - Sale+OE$132.63-20,0001,765,646-1%-$2,652,600
2021-04-05
MRNAModerna, Inc.Bancel StephaneCEOS - Sale$129.77-11,04622,992,5040%-$1,433,417
D
2021-04-05
XLRNAcceleron Pharma IncZakrzewski Joseph SDirS - Sale+OE$140.73-10,00034,499-22%-$1,407,343
D
2021-04-05
XLRNAcceleron Pharma IncSmith Karen L.DirS - Sale+OE$140.19-11,8641,622-88%-$1,663,156
D
2021-04-05
HALOHalozyme Therapeutics, Inc.Torley HelenPres, CEOS - Sale+OE$42.55-50,000537,160-9%-$2,127,250
M
2021-04-01
PSTXPoseida Therapeutics, Inc.Ostertag EricCEO, 10%S - Sale$9.61-115,0005,866,944-2%-$1,104,998
M
2021-01-05
CDTXCidara Therapeutics, Inc.Abdollahian NeilChief Business OfficerS - Sale$2.26-4,33757,471-7%-$9,816
M
2021-01-05
CDTXCidara Therapeutics, Inc.Daruwala PaulCOOS - Sale$2.16-3,46150,531-6%-$7,485
M
2021-01-05
CDTXCidara Therapeutics, Inc.Oien JessicaGC, SecretaryS - Sale$2.41-2,0017,764-20%-$4,828
D
2021-04-01
HARPHarpoon Therapeutics, Inc.Wesche HolgerChief Scientific OfficerS - Sale+OE$20.45-10,00052,852-16%-$204,491
D
2021-04-01
VIRVir Biotechnology, Inc.Parrish JayChief Business OfficerS - Sale+OE$51.40-6,9449,260-43%-$356,956
2021-04-01
DNLIDenali Therapeutics Inc.Tessier-Lavigne MarcDirS - Sale$56.62-50,0002,592,296-2%-$2,831,071
2021-04-01
DNLIDenali Therapeutics Inc.Watts Ryan J.Pres, CEOS - Sale$56.60-18,3342,404,099-1%-$1,037,684
2021-04-01
WINTWindtree Therapeutics Inc /de/Fraser CraigPres, CEOP - Purchase$2.46+50026,945+2%+$1,229
D
2021-03-31
ADPTAdaptive Biotechnologies CorpTaylor Stacy LSVP, GCS - Sale+OE$40.00-4,16715,036-22%-$166,680
D
2021-04-01
EXELExelixis, Inc.Lamb PeterEVP, Scientific Strategy, CSOS - Sale+OE$22.96-60,000406,572-13%-$1,377,600
D
2021-04-01
EXELExelixis, Inc.Schwab GiselaPres, Prod Dev, Med Aff, CMOS - Sale+OE$23.00-50,000628,362-7%-$1,150,000
D
2021-04-01
XLRNAcceleron Pharma IncZakrzewski Joseph SDirS - Sale+OE$134.64-10,00034,499-22%-$1,346,382

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top